rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    UTHR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      United Therapeutics CEO Rothblatt sells $5.58M in stock
      Nov 17Investing.comUTHR
      United Therapeutics CEO Rothblatt sells $5.6 million in shares
      Nov 17Investing.comUTHR
      United Therapeutics Prepares for TYVASO Expansion After $833 Million Quarter
      Nov 17Yahoo FinanceUTHR
      United Therapeutics at UBS Global Biopharma Conference 2026: 2027 catalyst year
      Nov 16Investing.comUTHRUBS
      United Therapeutics CEO Martine Rothblatt sells $4.77M in stock
      Nov 15Investing.comUTHR
      United Therapeutics CEO Rothblatt sells $5.57M in shares after option exercise
      Nov 13Investing.comUTHR
      Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today
      Nov 12BenzingaUTHR
      United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
      Nov 9Yahoo FinanceUTHR
      H.C. Wainwright raises United Therapeutics stock price target to $660
      Nov 9Investing.comUTHR
      The 5 most interesting analyst questions from United Therapeutics’s Q3 2026 earnings call
      Nov 8Yahoo FinanceUTHR
      United Therapeutics CEO Rothblatt sells $1.17M in stock
      Nov 7Investing.comUTHR
      Martine Rothblatt, United Therapeutics CEO, sells $4.3M in shares
      Nov 7Investing.comUTHR
      SPDR S&P MidCap 400 ETF (MDY) Adds Glaukos and United Therapeutics on Wednesday
      Nov 6Yahoo FinanceUTHRGKOSMDYMDYGSPMD
      United Therapeutics chairperson & CEO Rothblatt sells $1.05M shares
      Nov 6Investing.comUTHR
      Martine Rothblatt, United Therapeutics CEO, sells $4.66M in shares
      Nov 6Investing.comUTHR
      Wells Fargo raises United Therapeutics stock price target on ILD outlook
      Nov 5Investing.comUTHR
      United Therapeutics Corporation Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceUTHR
      United Therapeutics CEO Rothblatt sells $5.7M in shares
      Nov 4Investing.comUTHR
      What United Therapeutics (UTHR) Said on Its Q3 Earnings Call
      Nov 4Yahoo FinanceUTHR
      United Therapeutics Corp (UTHR) Q3 2026 Earnings Call Highlights: Record Revenue of $833 ...
      Nov 4Yahoo FinanceUTHR
      Raymond James raises United Therapeutics stock price target on revenue beat
      Nov 4Investing.comUTHR
      Earnings call transcript: United Therapeutics posts record Q3 revenue, misses EPS in 2026
      Nov 4Investing.comUTHR
      United Therapeutics Q3 2026 slides: record revenue, robust pipeline
      Nov 4Investing.comUTHR
      United Therapeutics (UTHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
      Nov 4Yahoo FinanceUTHR
      United Therapeutics buys out Pfizer royalties (PFE:NYSE)

      United Therapeutics (UTHR) stock rises as the company eliminates Pfizer (PFE) royalties linked to lung disease drug ralinepag for $525M. Read more here.

      Nov 4Seeking AlphaUTHRPFE
      United Therapeutics buys out Pfizer royalty for $525 million
      Nov 4Investing.comUTHRPFE
      United Therapeutics Announces Buydown of Ralinepag Royalty
      Nov 4Yahoo FinanceUTHR
      United Therapeutics earnings missed by $0.50, revenue topped estimates
      Nov 4Investing.comUTHR
      United Therapeutics (NASDAQ:UTHR) beats Q3 2026 sales expectations, stock soars
      Nov 4Yahoo FinanceUTHR
      United Therapeutics falls on Q3 earnings miss despite revenue beat
      Nov 4Investing.comUTHR
      United Therapeutics (UTHR) Q3 Earnings Miss Estimates
      Nov 4Yahoo FinanceUTHR
      United Therapeutics: Q3 Earnings Snapshot

      (AP) — United Therapeutics Corp. (UTHR) on Wednesday reported third-quarter profit of $258.

      Nov 4Yahoo FinanceUTHR
      United Therapeutics Corporation Reports Third Quarter 2026 Financial Results
      Nov 4Yahoo FinanceUTHR
      United Therapeutics faces earnings test after Liquidia win
      Nov 3Investing.comLQDAUTHR
      Varda Says One Spaceflight Could Make Medicine For Millions - United Therapeutics (NASDAQ:UTHR), Redwire
      Nov 2BenzingaUTHRRDW
      United Therapeutics evp Paul Mahon sells $4.1M in UTHR shares
      Nov 2Investing.comUTHR
      United Therapeutics stock hits all-time high at 609.99 USD
      Oct 30Investing.comUTHR
      United Therapeutics (UTHR) Cleared To Start Trial For New Pulmonary Hypertension Therapy

      United Therapeutics (NasdaqGS:UTHR) received FDA clearance to begin clinical trials of Treprostinil-Iloprost SMI for pulmonary arterial hypertension. The investigational therapy pairs two prostacyclin analogues and is designed as an as-needed treatment rather than continuous dosing. The business reported new designated pathogen-free xenotransplantation facilities in Houston and Stewartville to support commercial-scale xeno-organ production. Treprostinil-Iloprost SMI trial clearance and the...

      Oct 29Yahoo FinanceUTHR
      United Therapeutics Receives FDA Clearance to Begin Clinical Trial of Inhaled PAH Treatment
      Oct 28Yahoo FinanceUTHR
      $100 Invested In United Therapeutics 15 Years Ago Would Be Worth This Much Today
      Oct 28BenzingaUTHR
      Analysts Estimate United Therapeutics (UTHR) to Report a Decline in Earnings: What to Look Out for
      Oct 28Yahoo FinanceUTHR
      United Therapeutics gets FDA nod for PAH combination therapy trial
      Oct 28Investing.comUTHR
      United Therapeutics Rising Ahead of Next Earnings Report
      Oct 28Yahoo FinanceUTHR
      S&P 500 Futures Up in Premarket Trading; MSG Sports, United Therapeutics Lag
      Oct 27Barron'sUTHRMSGS
      United Therapeutics CEO sells $5.5M in stock
      Oct 26Investing.comUTHR
      Martine Rothblatt, United Therapeutics CEO, sells $5.5M in stock
      Oct 24Investing.comUTHR
      United Therapeutics CEO Rothblatt sells $5.3m in UTHR stock
      Oct 23Investing.comUTHR
      United Therapeutics Insider Sold Shares Worth $5,320,681, According to a Recent SEC Filing
      Oct 22Yahoo FinanceUTHR
      United Therapeutics' Tyvaso Outlook Faces Near-Term Pressure After Liquidia Settlement, RBC Says
      Oct 22Yahoo FinanceLQDAUTHR
      United Therapeutics Authorizes New $2 Billion Stock Buyback Program
      Oct 22Yahoo FinanceUTHR

      This is the newest page. Registered accounts read further back.